The FDA has approved bioLytical Laboratories' Insti HIV self test. The company touts it as the fastest home-use HIV test available in the U.S., ...
Consultant Gareth Patton said the work could have a big impact on lives [BBC] Patients treated in A&E in Aberdeen will be the first in the country to be routinely offered a potentially life-saving ...
More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
BETHLEHEM, Pa. (WPVI) -- A Lehigh Valley company that helped transform HIV testing is continuing its mission to improve public health through innovation and accessibility. OraSure Technologies, based ...
The Institute of Human Virology Nigeria (IHVN) has called on people living with HIV to remain committed to their prescribed ...
COLUMBIA, S.C. — September 22-26, 2025, is PrEP Awareness Week. South Carolina Department of Public Health (DPH) will be offering free STD/HIV testing at most local health department clinics in the ...
The intervention increased HIV cotesting rates in urgent care and emergency departments, improving diagnosis and care linkage. Electronic prompts for HIV tests during STI evaluations led to ...
PrEP drugs can prevent people who are HIV-negative from acquiring the virus. If a person is exposed to it, the injection works by blocking an enzyme called integrase, which HIV needs to make copies of ...
HIV and AIDS healthcare workers are uncertain about what the future holds in light of continuous federal funding cuts to ...
Science Africa on MSN
HIV: Challenges Remain as Kenya Set to Rollout Twice-yearly Injectable Drug
By Dickens Okinyi Kenya’s ongoing fight against HIV has entered a new phase with the roll out of Lenacapavir, a groundbreaking long-acting HIV prevention and treatment drug, set to take place in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results